Editorial: Covid-19 therapies in patients with hematologic malignancies
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-02-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1382268/full |
| _version_ | 1827347478471507968 |
|---|---|
| author | Andrea Visentin Massimo Gentile Massimo Gentile |
| author_facet | Andrea Visentin Massimo Gentile Massimo Gentile |
| author_sort | Andrea Visentin |
| collection | DOAJ |
| first_indexed | 2024-03-07T23:51:13Z |
| format | Article |
| id | doaj.art-84655475e6f943dda77eae3093e33a21 |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-03-07T23:51:13Z |
| publishDate | 2024-02-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-84655475e6f943dda77eae3093e33a212024-02-19T04:58:31ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2024-02-011410.3389/fonc.2024.13822681382268Editorial: Covid-19 therapies in patients with hematologic malignanciesAndrea Visentin0Massimo Gentile1Massimo Gentile2Hematology Unit, Department of Medicine, University of Padova, Padova, ItalyHematology Unit, Azienda Ospedaliera (AO) Cosenza, Cosenza, ItalyDepartment of Pharmacy, Health and Nutritional Science, University of Calabria, Rende, Italyhttps://www.frontiersin.org/articles/10.3389/fonc.2024.1382268/fullhematologic malignanciesCOVIDtixagevimab/cilgavimabvaccinerituximab |
| spellingShingle | Andrea Visentin Massimo Gentile Massimo Gentile Editorial: Covid-19 therapies in patients with hematologic malignancies Frontiers in Oncology hematologic malignancies COVID tixagevimab/cilgavimab vaccine rituximab |
| title | Editorial: Covid-19 therapies in patients with hematologic malignancies |
| title_full | Editorial: Covid-19 therapies in patients with hematologic malignancies |
| title_fullStr | Editorial: Covid-19 therapies in patients with hematologic malignancies |
| title_full_unstemmed | Editorial: Covid-19 therapies in patients with hematologic malignancies |
| title_short | Editorial: Covid-19 therapies in patients with hematologic malignancies |
| title_sort | editorial covid 19 therapies in patients with hematologic malignancies |
| topic | hematologic malignancies COVID tixagevimab/cilgavimab vaccine rituximab |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2024.1382268/full |
| work_keys_str_mv | AT andreavisentin editorialcovid19therapiesinpatientswithhematologicmalignancies AT massimogentile editorialcovid19therapiesinpatientswithhematologicmalignancies AT massimogentile editorialcovid19therapiesinpatientswithhematologicmalignancies |